COMPLICATIONS IN MOTHER AND BABY DUE TO DENGUE FEVER
Not Applicable
Recruiting
- Conditions
- Health Condition 1: null- All antenatal patients with Dengue fever in pregnancy irrespective of period of gestation, and they were followed up in the antepartum, intrapartum and till their postpartum stay in the hospital.
- Registration Number
- CTRI/2018/05/013740
- Lead Sponsor
- KERALA INSTITUTE OF MEDICAL SCIENCES
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.All antenatal women with laboratory confirmed Dengue virus infection, irrespective of their gestational age.
2.Women who give consent for the study.
Exclusion Criteria
1.All pregnant women with dengue positive, who does not report for follow up.
2.Women who refuses for the study.
3.Those cases from medical records with any missing data for study proforma.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method â?¢To study any adverse effects on fetus due to dengue fever during pregnancy specifically premature birth, low birth weight, intra-uterine fetal demise, birth asphyxia, admission in NICUTimepoint: nov 2017 to oct 2018
- Secondary Outcome Measures
Name Time Method 1.miscarriage, preterm labor, intrapartum and postpartum complications <br/ ><br>2.thrombocytopenia and bleeding manifestations, amount of blood and blood products transfused during pregnancy and postpartum. <br/ ><br>3.blood parameters specifically indicating DIC, ARF, liver injury, ICU admissions, and maternal mortality. <br/ ><br>4.the effect of oligohydramnios due to dengue fever on pregnancy. <br/ ><br>5.obstetrical and medical complications are high in reporting late or in late diagnosis of dengue fever <br/ ><br>Timepoint: nov 2017 to oct 2018
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link dengue fever to adverse maternal and fetal outcomes in pregnancy?
How does dengue virus infection during pregnancy compare to standard-of-care management in terms of fetal complications?
Are there specific biomarkers that predict severe dengue-related complications in pregnant women and their neonates?
What are the potential adverse events associated with dengue fever in pregnancy and effective management strategies?
What combination therapies or antiviral agents show promise in mitigating dengue fever complications during pregnancy?